Reported 2 days ago
Boston Scientific Corporation (NYSE:BSX) is highlighted as a significant innovative healthcare stock to watch in 2025, with impressive fourth-quarter earnings and a growth forecast amid increasing healthcare costs in the US. The company, specializing in medical devices, showed a 22.4% increase in net sales in Q4 2024 and is expanding through acquisitions, such as the recent purchase of SoniVie Ltd. Despite its potential, experts suggest that AI stocks may offer even greater investment returns in a shorter time frame.
Source: YAHOO